Welcome to our dedicated page for Cartesian Growth Corporation II Warrant news (Ticker: RENEW), a resource for investors and traders seeking the latest updates and insights on Cartesian Growth Corporation II Warrant stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cartesian Growth Corporation II Warrant's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cartesian Growth Corporation II Warrant's position in the market.
Cartesian Growth Corporation II announced that starting June 27, 2022, holders of units from its IPO can trade the shares and warrants separately. The units will continue to trade under the symbol RENEU, while the separated Class A ordinary shares and warrants will trade under RENE and RENEW on Nasdaq. A registration statement for these securities was declared effective by the SEC on May 5, 2022. This announcement does not constitute an offer to sell or buy securities where it is unlawful.
On May 10, 2022, Cartesian Growth Corporation II announced the closing of its initial public offering, raising $230 million from 23 million units priced at $10 each. The offering included an additional 3 million units due to an underwriters’ over-allotment option. The company's units will trade on Nasdaq under symbol 'RENEU', with Class A ordinary shares and warrants expected to trade under 'RENE' and 'RENEW', respectively. Cartesian Growth aims to engage in business combinations with high-growth companies, leveraging the expertise of its management team.
Cartesian Growth Corporation II has priced its initial public offering (IPO) at $10.00 per unit, comprising 20,000,000 units. Trading is set to begin on May 6, 2022, under the symbol RENEU on Nasdaq. Each unit includes one Class A ordinary share and one-third of a redeemable warrant, with whole warrants priced at $11.50 for one share. The offering will close around May 10, 2022, and underwriters have a 45-day option for an additional 3,000,000 units. The offering is managed by Cantor Fitzgerald & Co.
FAQ
What is the current stock price of Cartesian Growth Corporation II Warrant (RENEW)?
